| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Putative uncharacterized protein ;Spp1 ; |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Expression System | |
| Gene ID | |
| Immunogen | Expression system for standard: NS0; Immunogen sequence: L17-N294 |
| Product Type | |
| Reactivity | |
| Sample Type(s) | cell culture supernatants, serum, plasma (heparin, EDTA) and urine. |
| Sensitivity | |
| Storage | |
| Target | |
| UniProt # |
Background
Also known as: Putative uncharacterized protein, Spp1.
Mouse OPN / Osteopontin (SPP1) is widely studied as a molecular readout in experimental models where changes in protein abundance reflect underlying biology. This target is frequently investigated in Cell Signaling research contexts. As with many protein targets, abundance can be influenced by transcriptional regulation, secretion or shedding, proteolytic processing, and clearance. Quantitative measurement is often used to connect molecular changes with phenotypes such as stress responses, immune activation, differentiation, or tissue remodeling.
Biological context and interpretation
Protein-level readouts complement nucleic-acid measurements by reflecting post-transcriptional control and protein stability. Depending on the model system, changes may be transient or sustained, and may represent direct pathway engagement or secondary effects. When interpreting results, consider sample matrix effects, timing relative to stimulation or treatment, and whether complexes or modified forms of the analyte may be present.
Why it matters in research
- Comparative quantification: Supports analysis across experimental groups, time points, or dose ranges.
- Pathway context: Useful as part of a broader marker panel to triangulate biological mechanisms.
- Model characterization: Helps profile baseline vs perturbed states in cells, tissues, or biofluids.
Related pathways and interacting partners
For many targets, interpretability improves when measured alongside biologically connected markers (e.g., upstream regulators, downstream effectors, and cell-type indicators). Designing panels around a pathway hypothesis can help distinguish primary pathway activation from general stress or inflammation.
Sample data
| Concentration (pg/ml) | 0 | 156 | 312 | 625 | 1250 | 2500 | 5000 | 10000 |
| O.D. | 0.025 | 0.065 | 0.103 | 0.178 | 0.314 | 0.572 | 1.122 | 1.85 |
Intra/inter assay consistency
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 16 | 16 | 16 | 24 | 24 | 24 |
| Mean (pg/ml) | 306 | 1986 | 5401 | 308 | 2000 | 4959 |
| Standard deviation | 14.68 | 117.17 | 405.07 | 15.09 | 142 | 447.11 |
| CV (%) | 4.8% | 7.5% | 7.5% | 4.9% | 7.1% | 9% |
Kit components
Description|Quantity Pre-coated 96-well strip microplate|1 Standard|2 vials Biotinylated antibody (100x)|100ul Avidin-Biotin-Peroxidase Complex (100x)|100ul Sample Diluent|30ml Antibody Diluent|12ml Avidin-Biotin-Peroxidase Diluent|12ml Color Developing Reagent (TMB)|10ml Stop Solution|10ml Wash Buffer (25x)|20ml Adhesive plate sealers|4Materials required but not provided
- Microplate Reader capable of reading absorbance at 450nm.
- Incubator.
- Automated plate washer (optional).
- Pipettes and pipette tips capable of precisely dispensing 0.5 µl through 1 ml volumes of aqueous solutions.
- Multichannel pipettes are recommended for large amount of samples.
- Deionized or distilled water.
- 500ml graduated cylinders.
- Test tubes for dilution.
►How many samples can I run per plate?
►What sample dilution should I use?
►Why is my signal weak or absent?
►Why is my background signal high?
►Are the kit components sterile?
►How do I analyze my ELISA results?
►How should I store samples before running the assay?
►What positive and negative controls should I include?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
- Liu et al. (2025). Pro-Atherosclerotic Effects of Osteopontin Is Contributed to Promoting Foam Cell Formation Derived From VSMCs by Inhibit…. FASEB JOURNAL.
- Liu et al. (2025). Mycobacterium tuberculosis specific protein Rv1509 modulates osteoblast and osteoclast differentiation via TLR2 signalin…. iScience.
- Gani et al. (2025). Comparative study of bovine and synthetic hydroxyapatite in micro- and nanosized on osteoblasts action and bone growth. PLoS One.
- Ma et al. (2022). Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss. Frontiers in Pharmacology.
- Yin et al. (2019). Surface Epitaxial Crystallization-Directed Nanotopography for Accelerating Preosteoblast Proliferation and Osteogenic Di…. ACS Applied Materials & Interfaces.
- Yin et al. (2019). Nanotopographical polymeric surface with mussel-inspired decoration to enhance osteoblast differentiation. APPLIED SURFACE SCIENCE.
- Zhao et al. (2018). Promoting osteoblast proliferation on polymer bone substitutes with bone-like structure by combining hydroxyapatite and …. Materials Science & Engineering C-Materials for Biological Applications.
- Xu et al. (2018). Activated iRhom2 drives prolonged PM2.5 exposure-triggered renal injury in Nrf2-defective mice. Nanotoxicology.
- Qin et al. (2018). Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signa…. Theranostics.
- (2025). Osteopontin aggravates myocardial fibrosis by promoting phenotypic transition of cardiac fibroblasts via Hippo-YAP pathw….